查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930082

全球生物感測器市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測（2026-2034）

Biosensors Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 162 Pages | 商品交期: 請詢問到貨日

價格

生物感測器市場成長因素

受醫療和非醫療領域對快速、準確和微創診斷解決方案的需求不斷增長的推動，全球生物感測器市場正經歷強勁增長。 根據 Fortune Business Insights 預測，生物感測器市場規模預計將在 2025 年達到 298.8 億美元，並在 2026 年達到 326 億美元。在臨床診斷、健康監測和即時檢測等領域的日益普及推動下，該市場預計將在 2026 年至 2034 年間以 9.44% 的複合年增長率增長，到 2034 年達到 671 億美元。

北美地區擁有先進的醫療基礎設施、慢性病高發生率以及穿戴式裝置和即時診斷技術的廣泛應用，預計將在 2025 年佔全球生物感測器市場 44.53% 的佔有率。

市場概覽

生物感測器是一種分析設備，可以將來自酵素、細胞和組織的生物反應轉化為可測量的電訊號。 它們被廣泛應用於醫療診斷、農業、環境監測、食品安全和生物醫學研究等領域。在醫療保健領域，生物感測器能夠實現疾病的早期檢測、持續監測和無痛診斷，使其成為現代臨床實踐中不可或缺的工具。

全球糖尿病、心血管疾病和傳染病負擔的日益加重，顯著推動了對基於生物感測器的醫療設備的需求。此外，半導體製造商和醫療設備製造商之間的合作正在加速高精度生物感測器平台的開發，進一步促進市場成長。

新冠疫情的影響

2020年，新冠疫情加速了從集中式實驗室診斷向即時檢測和居家檢測的轉變，從而對生物感測器市場產生了積極影響。即使在疫情後時期，自測和穿戴式生物感測器設備的持續普及，也為2021年及以後的市場成長提供了支撐。 生物感測器在快速診斷、疾病監測和遠端患者監護方面發揮了關鍵作用。

生物感測器市場趨勢

生物感測器在糖尿病監測中的應用日益廣泛

生物感測器市場最顯著的趨勢之一是糖尿病監測設備的日益普及。採用電化學生物感測器的連續血糖監測 (CGM) 系統在醫院和家庭醫療保健機構的應用越來越廣泛。這些設備能夠實現即時監測、改善胰島素管理並提高患者的便利性。

據雅培公司稱，2021 年全球將有超過 300 萬人使用 FreeStyle Libre CGM 系統，這反映出市場對基於生物感測器的糖尿病解決方案的強勁需求。持續進行旨在將胰島素監測生物感測器與血糖感測器整合的研究和開發工作，預計將進一步擴大其應用範圍。

市場成長驅動因素

生物感測器技術進步

奈米材料、石墨烯基感測器、螢光標記和光纖技術的快速發展顯著提高了生物感測器的靈敏度、選擇性和準確性。這些創新正在拓展生物感測器的應用領域，包括藥物研發、癌症診斷和傳染病檢測。

例如，2022年1月，IDENTIFYSENSORS公司開發了一種基於石墨烯的SARS-CoV-2生物感測器，其靈敏度約為96.0%，凸顯了先進材料在下一代診斷技術中的重要作用。

限制因子

儘管市場成長潛力巨大，但仍面臨生產成本高、感測器穩定性有限和設備壽命短等挑戰。 感測器效能下降、漂移以及頻繁更換零件等問題可能會限制其長期應用，尤其是在資源有限的環境中。

市場區隔分析

依類型

市場可細分為電化學生物感測器、光學生物感測器、壓電生物感測器和其他類型。

受血糖監測設備廣泛應用的推動，電化學生物感測器預計將佔市場主導地位，到2026年將佔80.60%的市場佔有率。由於對非侵入式診斷的需求不斷增長，光學生物感測器預計將呈現最快的增長速度。

依應用

依應用劃分，市場包括臨床診斷、健康監測和其他領域。

受全球即時診斷（POC）檢測成長的推動，臨床診斷領域預計在2026年將佔最大的市場佔有率，達到67.22%。

依最終使用者劃分

市場依最終用戶分為醫療器材製造商、合約研發生產機構（CDMO）及其他。

醫療器材製造商在強勁的產品開發舉措和對配備生物感測器的醫療器材日益增長的需求的推動下，預計將在2026年佔73.14%的市場佔有率，成為市場主導者。

區域因素

受持續的產品發布和監管審批的推動，北美生物感測器市場預計將在2025年增長至133億美元，並在2026年增長至144.7億美元。

由於歐洲擁有雄厚的醫療研究資金和生物感測器研發（R&D）實力，歐洲佔了很大比例。

亞太地區預計將實現最高成長率，這主要得益於糖尿病患者數量的增加以及即時診斷技術的日益普及。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要公司研發支出概況（2025 年）
  • 生物感測器技術進步概覽
  • 關鍵產業趨勢：併購、業務夥伴關係
  • 新產品發布
  • 新冠疫情對市場的影響

第五章 全球生物感測器市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依類型劃分
    • 電化學生物感測器
    • 光學生物感測器
    • 壓電生物感測器
    • 其他
  • 市場分析、洞察與預測：依應用劃分
    • 臨床診斷
      • 血糖監測
      • 傳染病篩檢
      • 懷孕與不孕症檢測
      • 其他
    • 健康監測
      • 生命徵象監測
      • 活動監測
    • 其他
  • 市場分析，洞察與預測：依最終用戶劃分
    • 醫療器材製造商
    • CDMO（合約開發與生產組織）
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美生物感測器市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲生物感測器市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國王國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲國家

第八章 亞太生物感測器市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 澳大利亞
    • 中國
    • 印度
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲生物感測器市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第十章 中東與非洲生物感測器市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會 (GCC)
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 全球市佔率分析（2025）
  • 公司簡介
    • Abbott
    • Medtronic
    • F. Hoffmann-La Roche Ltd.
    • Universal Biosensors
    • DuPont
    • Biosensors International Group, Ltd.
    • Bio-Rad Laboratories Inc.
    • Koninklijke Philips N.V.
    • LifeScan IP Holdings, LLC
    • Molecular Devices, LLC.
Product Code: FBI100146

Growth Factors of biosensors Market

The global biosensors market is witnessing strong growth due to rising demand for rapid, accurate, and minimally invasive diagnostic solutions across healthcare and non-healthcare applications. According to Fortune Business Insights, the biosensors market size was valued at USD 29.88 billion in 2025 and is projected to grow to USD 32.60 billion in 2026. With expanding adoption across clinical diagnostics, health monitoring, and point-of-care testing, the market is forecasted to reach USD 67.10 billion by 2034, exhibiting a CAGR of 9.44% during the 2026-2034 forecast period.

North America dominated the global biosensors market with a 44.53% share in 2025, supported by advanced healthcare infrastructure, high prevalence of chronic diseases, and strong adoption of wearable and point-of-care diagnostic technologies.

Market Overview

Biosensors are analytical devices that convert biological responses from enzymes, cells, or tissues into measurable electrical signals. These devices are widely used across medical diagnostics, agriculture, environmental monitoring, food safety, and biomedical research. In healthcare, biosensors enable early disease detection, continuous monitoring, and pain-free diagnostics, making them essential tools in modern clinical practice.

The increasing global burden of diabetes, cardiovascular diseases, and infectious disorders has significantly boosted demand for biosensor-based medical devices. Additionally, collaborations between semiconductor manufacturers and medical device companies are accelerating the development of highly precise biosensor platforms, further driving market growth.

Impact of COVID-19

The COVID-19 pandemic positively influenced the biosensors market in 2020 by accelerating the shift from centralized laboratory diagnostics to point-of-care and home-based testing. Increased adoption of self-testing and wearable biosensor-enabled devices continued during the post-pandemic period, supporting market growth in 2021 and beyond. Biosensors played a critical role in rapid diagnosis, disease surveillance, and remote patient monitoring.

Biosensors Market Trends

Rising Adoption of Biosensors for Diabetes Monitoring

One of the most prominent trends in the biosensors market is the growing deployment of devices for diabetes monitoring. Continuous glucose monitoring (CGM) systems using electrochemical biosensors are increasingly adopted across hospitals and homecare settings. These devices offer real-time monitoring, improved insulin management, and enhanced patient convenience.

According to Abbott, more than 3.0 million people worldwide were using the FreeStyle Libre CGM system in 2021, reflecting strong demand for biosensor-enabled diabetes solutions. Ongoing R&D efforts aimed at integrating insulin-monitoring biosensors with glucose sensors are expected to further strengthen adoption.

Market Growth Factors

Technological Advancements in Biosensors

Rapid advancements in nanomaterials, graphene-based sensors, fluorescence tagging, and fiber-optic technologies are significantly improving biosensor sensitivity, selectivity, and accuracy. These innovations are expanding biosensor applications across drug discovery, cancer diagnostics, and infectious disease testing.

For example, in January 2022, IDENTIFYSENSORS developed a graphene-based SARS-CoV-2 biosensor with approximately 96.0% sensitivity, highlighting the role of advanced materials in next-generation diagnostics.

Restraining Factors

Despite strong growth potential, the market faces challenges such as high production costs, limited sensor stability, and short device lifespan. Issues related to sensor degradation, drift, and frequent component replacement can restrict long-term adoption, particularly in resource-limited settings.

Segmentation Analysis

By Type

The market is segmented into electrochemical biosensors, optical biosensors, piezoelectric biosensors, and others.

Electrochemical biosensors dominated the market with an 80.60% share in 2026, driven by widespread adoption of glucose monitoring devices. Optical biosensors are expected to grow at the fastest rate due to increasing demand for non-invasive diagnostics.

By Application

Based on application, the market includes clinical diagnostics, health monitoring, and others.

The clinical diagnostics segment held the largest share of 67.22% in 2026, supported by the rising number of point-of-care diagnostic tests worldwide.

By End User

By end user, the market is segmented into medical device companies, CDMOs, and others.

Medical device companies dominated the market with a 73.14% share in 2026, owing to strong product development initiatives and growing demand for biosensor-enabled healthcare devices.

Regional Insights

The North America biosensors market was valued at USD 13.30 billion in 2025 and increased to USD 14.47 billion in 2026, driven by continuous product launches and regulatory approvals.

Europe held a significant share due to strong healthcare research funding and biosensor R&D initiatives.

Asia Pacific is expected to record the highest growth rate, supported by rising diabetes prevalence and increasing adoption of point-of-care diagnostics.

Competitive Landscape

The biosensors market is dominated by key players such as Abbott, Medtronic, F. Hoffmann-La Roche Ltd., DuPont, Universal Biosensors, and Koninklijke Philips N.V. These companies focus on strategic collaborations, product launches, and technological innovation to strengthen their global presence.

Conclusion

In conclusion, the global biosensors market, valued at USD 29.88 billion in 2025, is projected to grow to USD 32.60 billion in 2026 and further reach USD 67.10 billion by 2034. Growth is driven by rising chronic disease prevalence, technological advancements, and expanding adoption of point-of-care and home-based diagnostic solutions.

Growth Rate CAGR of 9.44% from 2026-2034

Segmentation By Type

  • Electrochemical Biosensors
  • Optical Sensors
  • Piezoelectric Sensors
  • Others

By Application

  • Clinical Diagnostics
    • Glucose Monitoring
    • Infectious Disease Screening
    • Pregnancy & Fertility Testing
    • Others
  • Health Monitoring
    • Vital Signs Monitoring
    • Activity Tracking
  • Others

By End User

  • Medical Device Companies
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Others

By Region

  • North America (By Type, By Application, By End User and By Country)
    • U.S.
    • Canada
  • Europe (By Type, By Application, By End User and By Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Type, By Application, By End User and By Country/Sub-region)
    • Japan
    • China
    • India
    • Southeast Asia
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Type, By Application, By End User and By Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By Application, By End User and By Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview of R&D Expenditure, Key Players, 2025
  • 4.2. Overview: Technological Advancements in Biosensors
  • 4.3. Key Industry Developments - Partnerships, Mergers & Acquisitions
  • 4.4. New Product Launches
  • 4.5. Impact of COVID-19 on the Market

5. Global Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Electrochemical Biosensors
    • 5.1.2. Optical Biosensors
    • 5.1.3. Piezoelectric Biosensors
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Clinical Diagnostics
      • 5.2.1.1. Glucose Monitoring
      • 5.2.1.2. Infectious Disease Screening
      • 5.2.1.3. Pregnancy & Fertility Testing
      • 5.2.1.4. Others
    • 5.2.2. Health Monitoring
      • 5.2.2.1. Vital Signs Monitoring
      • 5.2.2.2. Activity Tracking
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Medical Device Companies
    • 5.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Electrochemical Biosensors
    • 6.1.2. Optical Biosensors
    • 6.1.3. Piezoelectric Biosensors
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Clinical Diagnostics
      • 6.2.1.1. Glucose Monitoring
      • 6.2.1.2. Infectious Disease Screening
      • 6.2.1.3. Pregnancy & Fertility Testing
      • 6.2.1.4. Others
    • 6.2.2. Health Monitoring
      • 6.2.2.1. Vital Signs Monitoring
      • 6.2.2.2. Activity Tracking
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Medical Device Companies
    • 6.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 6.3.3. Others
  • 6.4. Market Analysis - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Electrochemical Biosensors
    • 7.1.2. Optical Biosensors
    • 7.1.3. Piezoelectric Biosensors
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Clinical Diagnostics
      • 7.2.1.1. Glucose Monitoring
      • 7.2.1.2. Infectious Disease Screening
      • 7.2.1.3. Pregnancy & Fertility Testing
      • 7.2.1.4. Others
    • 7.2.2. Health Monitoring
      • 7.2.2.1. Vital Signs Monitoring
      • 7.2.2.2. Activity Tracking
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Medical Device Companies
    • 7.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 7.3.3. Others
  • 7.4. Market Analysis - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Rest of Europe

8. Asia pacific Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Electrochemical Biosensors
    • 8.1.2. Optical Biosensors
    • 8.1.3. Piezoelectric Biosensors
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Clinical Diagnostics
      • 8.2.1.1. Glucose Monitoring
      • 8.2.1.2. Infectious Disease Screening
      • 8.2.1.3. Pregnancy & Fertility Testing
      • 8.2.1.4. Others
    • 8.2.2. Health Monitoring
      • 8.2.2.1. Vital Signs Monitoring
      • 8.2.2.2. Activity Tracking
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Medical Device Companies
    • 8.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 8.3.3. Others
  • 8.4. Market Analysis - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. Australia
    • 8.4.3. China
    • 8.4.4. India
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Electrochemical Biosensors
    • 9.1.2. Optical Biosensors
    • 9.1.3. Piezoelectric Biosensors
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Clinical Diagnostics
      • 9.2.1.1. Glucose Monitoring
      • 9.2.1.2. Infectious Disease Screening
      • 9.2.1.3. Pregnancy & Fertility Testing
      • 9.2.1.4. Others
    • 9.2.2. Health Monitoring
      • 9.2.2.1. Vital Signs Monitoring
      • 9.2.2.2. Activity Tracking
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Medical Device Companies
    • 9.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Electrochemical Biosensors
    • 10.1.2. Optical Biosensors
    • 10.1.3. Piezoelectric Biosensors
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Clinical Diagnostics
      • 10.2.1.1. Glucose Monitoring
      • 10.2.1.2. Infectious Disease Screening
      • 10.2.1.3. Pregnancy & Fertility Testing
      • 10.2.1.4. Others
    • 10.2.2. Health Monitoring
      • 10.2.2.1. Vital Signs Monitoring
      • 10.2.2.2. Activity Tracking
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Medical Device Companies
    • 10.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Abbott
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Medtronic
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. F. Hoffmann-La Roche Ltd.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Universal Biosensors
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. DuPont
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Biosensors International Group, Ltd.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Bio-Rad Laboratories Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Koninklijke Philips N.V.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. LifeScan IP Holdings, LLC
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Molecular Devices, LLC.
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 4: Global Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 5: Global Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 6: Global Biosensors Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 8: North America Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 9: North America Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 10: North America Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 11: North America Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 12: North America Biosensors Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 14: Europe Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 15: Europe Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 16: Europe Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 17: Europe Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 18: Europe Biosensors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 20: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 21: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 22: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 23: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 24: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 26: Latin America Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 27: Latin America Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 28: Latin America Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 29: Latin America Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 30: Latin America Biosensors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 32: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 33: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 34: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 35: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 36: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Biosensors Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Biosensors Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Biosensors Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Biosensors Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Biosensors Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Biosensors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 7: North America Biosensors Market Value Share (%), by Type, 2025
  • Figure 8: North America Biosensors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Biosensors Market Value Share (%), by Application, 2025
  • Figure 10: North America Biosensors Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 11: North America Biosensors Market Value Share (%), by End-user, 2025
  • Figure 12: North America Biosensors Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Biosensors Market Value Share (%), By Country, 2025
  • Figure 14: Europe Biosensors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 15: Europe Biosensors Market Value Share (%), by Type, 2025
  • Figure 16: Europe Biosensors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Biosensors Market Value Share (%), by Application, 2025
  • Figure 18: Europe Biosensors Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: Europe Biosensors Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Biosensors Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Biosensors Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Biosensors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Biosensors Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Biosensors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Biosensors Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Biosensors Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Biosensors Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Biosensors Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Biosensors Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Biosensors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 31: Latin America Biosensors Market Value Share (%), by Type, 2025
  • Figure 32: Latin America Biosensors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Biosensors Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Biosensors Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Latin America Biosensors Market Value Share (%), by End-user, 2025
  • Figure 36: Latin America Biosensors Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Biosensors Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Biosensors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 39: Middle East & Africa Biosensors Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa Biosensors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Biosensors Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Biosensors Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Biosensors Market Value Share (%), by End-user, 2025
  • Figure 44: Middle East & Africa Biosensors Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Biosensors Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Biosensors Market Share (%), By Company, 2025